Sign In / Register
Make This My Home Page | Feedback |RSS
You are here: IE »   Story

Health Ministry mulls changes in MTP Act

  • Print
  • Mail This Article
  • Comments
  • Add to favorites
  • The Niketa Mehta case has forced the Union Health Ministry to mull changes in the Medical Termination of Pregnancy Act. At a meeting held last week, Union Health Minister Anbumani Ramadoss directed experts to study the Act and compare it with the relevant laws in other countries.

    “The Act is quite old and it is necessary to look at it. If the experts think that the Act requires amendments, we will work towards that,” said Ramadoss. “I am expecting comprehensive recommendations from the experts,” he added.

    In India, an unwanted pregnancy can be terminated till 20 weeks, while it is 24 weeks in US, UK and Canada, and 28 weeks in Australia. Niketa Mehta, a resident of Mumbai, had approached the court seeking to abort her 24-week foetus after it was found to have a congenital heart blockage. Over a week after the court turned down her plea, she suffered a miscarriage.

    Ads by Google

    The Health Ministry feels it is necessary to take a re-look at the Act, keeping in mind the advancements in science and technology.

    Comments
    Post comment

    Be the first to comment.

    Post a Comment
    Name:
    Email:
    Title:
    Maximum characters allowed     
    Comment:
    TERMS OF USE:
    The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
    I agree to the terms of use.